Drug Type Small molecule drug |
Synonyms DW-4421, ID-120040002, ID120040002 |
Target |
Action- |
Mechanism P-CAB(Potassium-competitive acid blockers) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H20FN3O4S |
InChIKeyUDMABANYJMEZDH-UHFFFAOYSA-N |
CAS Registry2756367-23-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-erosive gastro-esophageal reflux disease | Phase 3 | South Korea | 27 Oct 2025 | |
| Erosive gastro-esophageal reflux disease | Phase 3 | South Korea | 15 Oct 2025 | |
| Gastroesophageal Reflux | Phase 2 | South Korea | 01 Nov 2022 |





